[go: up one dir, main page]

Mohell et al., 1989 - Google Patents

Comparison of the pharmacological profiles of adrenergic drugs (including BRL-agonists) at [3H] prazosin and [3H] CGP-12177 binding sites in brown adipose tissue

Mohell et al., 1989

Document ID
4965545300395747040
Author
Mohell N
Nedergaard J
Publication year
Publication venue
Comparative Biochemistry and Physiology Part C: Comparative Pharmacology

External Links

Snippet

In order to determine the selectivity of classical and novel adrenergic agents for α 1-and β- adrenergic receptors in brown adipose tissue, the ability of these agents to compete for binding sites labelled with [3 H] prazosin and [3 H] CGP-12177, respectively, was …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Similar Documents

Publication Publication Date Title
Mohell et al. The β-adrenergic radioligand [3H] CGP-12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue
Williams et al. Binding of the nicotinic cholinergic antagonist, dihydro-beta-erythroidine, to rat brain tissue
Ruat et al. Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I] iodinated probes.
Tanaka et al. Binding of 3H-clonidine to an α-adrenoceptor in membranes of guinea-pig ileum
Hertel et al. Receptor-specific mechanisms of desensitization of β-adrenergic receptor function
US4894219A (en) Beta-agonist carbostyril derivatives, assay method and pharmacological composition
Closse [3H] Mesulergine, a selective ligand for serotonin-2 receptors
EP1949901A2 (en) Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
Malmberg et al. Site‐Directed Mutations in the Third Intracellular Loop of the Serotonin 5‐HT1A Receptor Alter G Protein Coupling from Gi to Gs in a Ligand‐Dependent Manner
Woodcock et al. Changes in tissue alpha-and beta-adrenergic receptors in renal hypertension in the rat.
Oshita et al. Pharmacological characterization of two distinct α1‐adrenoceptor subtypes in rabbit thoracic aorta
Malmberg et al. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5′-[γ-thio] triphosphate-[35S] binding
Sarsero et al. Validity of (−)‐[3H]‐CGP 12177A as a radioligand for the ‘putative β4‐adrenoceptor’in rat atrium
Arnett et al. Denervation-induced changes in alpha and beta adrenergic receptors of the rat submandibular gland.
Reisine et al. Activation of beta 2-adrenergic receptors on mouse anterior pituitary tumor cells increases cyclic adenosine 3': 5'-monophosphate synthesis and adrenocorticotropin release
Mohell et al. Comparison of the pharmacological profiles of adrenergic drugs (including BRL-agonists) at [3H] prazosin and [3H] CGP-12177 binding sites in brown adipose tissue
Kobayashi et al. Subtypes of β-adrenergic receptors in rat cerebral microvessels
Hughes et al. Agonist-mediated regulation of alpha 1-and beta 2-adrenergic receptor metabolism in a muscle cell line, BC3H-1.
Liao et al. Specific receptor-guanine nucleotide binding protein interaction mediates the release of endothelium-derived relaxing factor.
Recht et al. Effects of β-funaltrexamine on radiolabeled opioid binding
Hata et al. Characteristics of [3H] E-643-binding to alpha adrenoceptors
Sheppard Catecholamine hormone receptor differences identified on 3T3 and simian virus-transformed 3T3 cells.
Simasko et al. Structure-activity relationship for substance P inhibition of carbamylcholine-stimulated 22Na+ flux in neuronal (PC12) and non-neuronal (BC3H1) cell lines.
Sladeczek et al. Differences between agonist and antagonist binding to alpha 1-adrenergic receptors of intact and broken-cell preparations.
Brodde et al. No evidence for temperature-dependent changes in the pharmacological specificity of β 1-adrenoceptors